市場調査レポート
商品コード
1184189

整形外科用バイオマテリアルの世界市場:規模、シェア、COVID-19の影響分析(2023年~2029年):MedCore

Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

出版日: | 発行: iData Research Inc. | ページ情報: 英文 421 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
整形外科用バイオマテリアルの世界市場:規模、シェア、COVID-19の影響分析(2023年~2029年):MedCore
出版日: 2022年12月20日
発行: iData Research Inc.
ページ情報: 英文 421 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の整形外科用バイオマテリアルの市場規模は、2022年に56億米ドルとなりました。同市場は、予測期間中に3.4%のCAGRで拡大し、71億米ドルに達すると予測されています。

当レポートでは、世界の整形外科用バイオマテリアル市場について調査し、市場の概要とともに、セグメント別、地域別動向、競合情勢などを提供しています。

目次

調査手法

世界の整形外科用バイオマテリアル市場に対するCOVID-19の影響

  • イントロダクション
  • 地域プロファイル
  • 市場セグメント別分析

製品評価

  • イントロダクション
  • 製品ポートフォリオ
    • 骨移植代用品
    • 成長因子
    • 細胞療法
    • ヒアルロン酸関節内補充療法(HAV)
    • 軟骨修復
  • 規制上の問題とリコール
  • 臨床試験

世界の整形外科用バイオマテリアル市場概要

  • イントロダクション
  • 市場概要と動向分析
    • セグメント別
    • 地域別
  • 促進要因と抑制要因
  • 競合市場シェア分析
  • 合併と買収
  • 企業プロファイル
    • Arthrex
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici
    • Harvest Technologies (Terumo BCT)
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • Surgalign Holdings (former RTI Surgical)
    • Sanofi
    • SeaSpine
    • Stryker
    • Vericel
    • Zimmer Biomet
  • SWOT分析

整形外科用代用骨移植片市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
    • セグメント別
    • 地域別
  • 市場分析と予測
  • 個数分析
  • 促進要因と抑制要因
  • 競合市場シェア分析

整形外科用成長因子市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

整形外科用細胞療法市場

  • エグゼクティブサマリー
  • イントロダクション
    • 多血小板血漿
    • 骨髄穿刺濃縮細胞液
  • 手技件数
  • 市場概要
    • セグメント別
    • 地域別
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

ヒアルロン酸関節内補充療法市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
    • セグメント別
    • 地域別
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

付録:整形外科用軟骨修復市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

略語

図表

LIST OF CHARTS

  • Chart 1-1: Orthopedic Biomaterials Device Market by Segment, Global, 2022 - 2029
  • Chart 1-2: Orthopedic Bone Graft Substitute Procedures, Global, 2022
  • Chart 2-1: Multi-Scenario Orthopedic Biomaterials Device Market Forecast, Global, 2019 - 2029 (US$M)
  • Chart 4-1: Orthopedic Biomaterials Device Market by Segment, Global, 2019 - 2029
  • Chart 4-2: Orthopedic Biomaterials Device Market by Region, Global, 2019 - 2029
  • Chart 4-3: Leading Competitors, Orthopedic Biomaterials Device Market, Global, 2022
  • Chart 5-1: Orthopedic Bone Graft Substitute Market, Global, 2022 & 2029
  • Chart 5-2: Orthopedic Bone Graft Substitute Procedures, Global, 2022
  • Chart 5-3: Orthopedic Bone Grafting Procedures by Segment, Global, 2019 - 2029
  • Chart 5-4: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2019 - 2029
  • Chart 5-5: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2019 - 2029
  • Chart 5-6: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2022
  • Chart 6-1: Orthopedic Growth Factor Market, Global, 2022 & 2029
  • Chart 6-2: Orthopedic Growth Factor Procedures, Global, 2022
  • Chart 6-3: Orthopedic Growth Factor Procedures by Segment, Global, 2019 - 2029
  • Chart 6-4: Orthopedic Growth Factor Device Market, Global, 2019 - 2029
  • Chart 6-5: Leading Competitors, Orthopedic Growth Factor Market, Global, 2022
  • Chart 7-1: Orthopedic Cell Therapy Market, Global, 2022 & 2029
  • Chart 7-2: Orthopedic Cell Therapy Procedures, Global, 2022
  • Chart 7-3: Orthopedic Cell Therapy Procedures by Segment, Global, 2019 - 2029
  • Chart 7-4: Orthopedic Cell Therapy Device Market by Segment, Global, 2019 - 2029
  • Chart 7-5: Orthopedic Cell Therapy Device Market by Region, Global, 2019 - 2029
  • Chart 7-6: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2022
  • Chart 8-1: Hyaluronic Acid Viscosupplementation Market, Global, 2022 & 2029
  • Chart 8-2: Hyaluronic Acid Viscosupplementation Procedures, Global, 2022
  • Chart 8-3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Segment, Global, 2019 - 2029
  • Chart 8-4: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2019 - 2029
  • Chart 8-5: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2019 - 2029
  • Chart 8-6: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2022
  • Chart 9-1: Orthopedic Cartilage Repair Market, Global, 2022 & 2029
  • Chart 9-2: Orthopedic Cartilage Repair Procedures, Global, 2022
  • Chart 9-3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2019 - 2029
  • Chart 9-4: Orthopedic Cartilage Repair Device Market by Segment, Global, 2019 - 2029
  • Chart 9-5: Orthopedic Cartilage Repair Device Market by Region, Global, 2019 - 2029

LIST OF FIGURES

  • Figure 1-1: Orthopedic Biomaterials Device Market Share Ranking by Segment, Global, 2022
  • Figure 1-2: Companies Researched in This Report
  • Figure 1-3: Factors Impacting the Orthopedic Biomaterials Device Market by Segment, Global
  • Figure 1-4: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2019 - 2022
  • Figure 1-5: Orthopedic Biomaterial Procedures Covered
  • Figure 1-6: Orthopedic Biomaterial Regions Covered, Global (1 of 2)
  • Figure 1-7: Version History
  • Figure 2-1: Orthopedic Biomaterials Device Market by Segment, Worst Case Scenario, Global, 2019 - 2029 (US$M)
  • Figure 2-2: Orthopedic Biomaterials Device Market by Segment, Base Case Scenario, Global, 2019 - 2029 (US$M)
  • Figure 2-3: Orthopedic Biomaterials Device Market by Segment, Best Case Scenario, Global, 2019 - 2029 (US$M)
  • Figure 3-1: Bone Graft Substitute Products by Company (1 of 4)
  • Figure 3-2: Bone Graft Substitute Products by Company (2 of 4)
  • Figure 3-3: Bone Graft Substitute Products by Company (3 of 4)
  • Figure 3-4: Bone Graft Substitute Products by Company (4 of 4)
  • Figure 3-5: Growth Factor Products by Company
  • Figure 3-6: Cell Therapy Products by Company
  • Figure 3-7: Hyaluronic Acid Viscosupplementation by Products by Company
  • Figure 3-8: Cartilage Repair Products by Company
  • Figure 3-9: Class 2 Device Recall Bioactive Bone Graft Putty
  • Figure 3-10: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty
  • Figure 3-11: Class 2 Device Recall Opteform Allograft Disc
  • Figure 3-12: Class 2 Device Recall INFUSE Bone Graft X SMALL KIT
  • Figure 3-13: Class 2 Device Recall SynviscOne
  • Figure 3-14: Class 2 Device Recall PROSTIM 10cc INJECTABLE
  • Figure 3-15: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty
  • Figure 3-16: Class 1 Device Recall EBI Osteogen Implantable Bone Growth Stimulator
  • Figure 3-17: NOVOCART 3D Treatment Following Microfracture Failure
  • Figure 3-18: NOVOCART®3D for Treatment of Articular Cartilage of the Knee (N3D)
  • Figure 3-19: Demineralized Bone Matrix Rotator Cuff Study
  • Figure 3-20: ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery
  • Figure 3-21: A Post Market Surveillance on INFUSE Bone Graft
  • Figure 3-22: Prospective SPINE Registry (SPINE)
  • Figure 3-23: ACDF Using Structural Allograft vs. Tritanium C
  • Figure 3-24: Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee (NINJA)
  • Figure 3-25: Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients (JUNOVO)
  • Figure 3-26: NOVOCART® Inject Plus for Cartilage Defects of the Knee
  • Figure 3-27: Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture in Knee Cartilage Defects (N3D)
  • Figure 3-28: A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee (PEAK)
  • Figure 3-29: Clinical Study to Evaluate Adaptos®Ortho Wedge Bone Graft Substitute in High Tibial Osteotomy: A Randomized, Controlled, Partially Blinded, Multi-Center Trial
  • Figure 3-30: Novel Porous Bioceramic Material as a Bone Substitute
  • Figure 3-31: Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE)
  • Figure 3-32: Multicentric Observational Study on the Use of a Human Bone Graft in Osteochondral Defects
  • Figure 3-33: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft
  • Figure 3-34: A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle
  • Figure 3-35: Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
  • Figure 3-36: Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
  • Figure 3-37: PRP Versus HA in Osteoarthritis of the Patellofemoral Joint
  • Figure 3-38: The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome (PRP)
  • Figure 3-39: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
  • Figure 3-40: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain
  • Figure 3-41: A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis
  • Figure 3-42: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC)
  • Figure 3-43: Bone Marrow Aspirate Concentrate Use in Hip Osteoarthritis (BMAC)
  • Figure 3-44: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis.
  • Figure 3-45: Clinical Registry Assessment of the Missouri Osteochondral Allograft Preservation System - MOPS
  • Figure 3-46: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
  • Figure 3-47: Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation
  • Figure 3-48: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
  • Figure 3-49: A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects
  • Figure 3-50: Phase 2 Clinical Trial of CartiLife® in the United States
  • Figure 4-1: Orthopedic Biomaterials Device Market by Segment, Global, 2019 - 2029 (US$M)
  • Figure 4-2: Orthopedic Biomaterials Device Market by Region, Global, 2019 - 2029 (US$M)
  • Figure 4-3: Leading Competitors, Orthopedic Biomaterials Device Market by Segment, Global, 2022
  • Figure 4-4: SWOT Analysis, Arthrex
  • Figure 4-5: SWOT Analysis, Bioventus
  • Figure 4-6: SWOT Analysis, DePuy Synthes
  • Figure 4-7: SWOT Analysis, Ferring Pharmaceuticals
  • Figure 4-8: SWOT Analysis, Fidia Farmaceutici
  • Figure 4-9: SWOT Analysis, Harvest Technologies
  • Figure 4-10: SWOT Analysis, Medtronic
  • Figure 4-11: SWOT Analysis, MTF
  • Figure 4-12: SWOT Analysis, Surgalign Holdings
  • Figure 4-13: SWOT Analysis, Sanofi
  • Figure 4-14: SWOT Analysis, Sanofi
  • Figure 4-15: SWOT Analysis, Stryker
  • Figure 4-16: SWOT Analysis, Vericel Corporation
  • Figure 4-17: SWOT Analysis, Zimmer Biomet
  • Figure 5-1: Orthopedic Bone Graft Substitute Regions Covered, Global (1 of 2)
  • Figure 5-2: Orthopedic Bone Grafting Procedures by Segment, Global, 2019 - 2029
  • Figure 5-3: Orthopedic Bone Grafting Procedures by Region, Global, 2019 - 2029
  • Figure 5-4: Orthopedic Bone Grafting Procedures by Country, North America, 2019 - 2029
  • Figure 5-5: Orthopedic Bone Grafting Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 5-6: Orthopedic Bone Grafting Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 5-7: Orthopedic Bone Grafting Procedures by Country, Western Europe, 2019 - 2029
  • Figure 5-8: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 5-9: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 5-10: Orthopedic Bone Grafting Procedures by Country, Middle East, 2019 - 2029
  • Figure 5-11: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 5-12: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 5-13: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 5-14: Orthopedic Bone Grafting Procedures by Country, Africa, 2019 - 2029
  • Figure 5-15: Allograft Procedures by Region, Global, 2019 - 2029
  • Figure 5-16: Allograft Procedures by Country, North America, 2019 - 2029
  • Figure 5-17: Allograft Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 5-18: Allograft Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 5-19: Allograft Procedures by Country, Western Europe, 2019 - 2029
  • Figure 5-20: Allograft Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 5-21: Allograft Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 5-22: Allograft Procedures by Country, Middle East, 2019 - 2029
  • Figure 5-23: Allograft Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 5-24: Allograft Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 5-25: Allograft Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 5-26: Allograft Procedures by Country, Africa, 2019 - 2029
  • Figure 5-27: Demineralized Bone Matrix Procedures by Region, Global, 2019 - 2029
  • Figure 5-28: Demineralized Bone Matrix Procedures by Country, North America, 2019 - 2029
  • Figure 5-29: Demineralized Bone Matrix Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 5-30: Demineralized Bone Matrix Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 5-31: Demineralized Bone Matrix Procedures by Country, Western Europe, 2019 - 2029
  • Figure 5-32: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 5-33: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 5-34: Demineralized Bone Matrix Procedures by Country, Middle East, 2019 - 2029
  • Figure 5-35: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 5-36: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 5-37: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 5-38: Demineralized Bone Matrix Procedures by Country, Africa, 2019 - 2029
  • Figure 5-39: Synthetic Procedures by Region, Global, 2019 - 2029
  • Figure 5-40: Synthetic Procedures by Country, North America, 2019 - 2029
  • Figure 5-41: Synthetic Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 5-42: Synthetic Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 5-43: Synthetic Procedures by Country, Western Europe, 2019 - 2029
  • Figure 5-44: Synthetic Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 5-45: Synthetic Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 5-46: Synthetic Procedures by Country, Middle East, 2019 - 2029
  • Figure 5-47: Synthetic Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 5-48: Synthetic Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 5-49: Synthetic Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 5-50: Synthetic Procedures by Country, Africa, 2019 - 2029
  • Figure 5-51: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2019 - 2029 (US$M)
  • Figure 5-52: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2019 - 2029 (US$M)
  • Figure 5-53: Orthopedic Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-54: Units Sold by Region, Orthopedic Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-55: Average Selling Price by Region, Orthopedic Bone Graft Substitute Market, Global, 2019 - 2029 (US$)
  • Figure 5-56: Market Value by Region, Orthopedic Bone Graft Substitute Market, Global, 2019 - 2029 (US$M)
  • Figure 5-57: Allograft Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-58: Units Sold by Region, Allograft Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-59: Average Selling Price by Region, Allograft Bone Graft Substitute Market, Global, 2019 - 2029 (US$)
  • Figure 5-60: Market Value by Region, Allograft Bone Graft Substitute Market, Global, 2019 - 2029 (US$M)
  • Figure 5-61: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-62: Units Sold by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-63: Average Selling Price by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 - 2029 (US$)
  • Figure 5-64: Market Value by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 - 2029 (US$M)
  • Figure 5-65: Synthetic Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-66: Units Sold by Region, Synthetic Bone Graft Substitute Market, Global, 2019 - 2029
  • Figure 5-67: Average Selling Price by Region, Synthetic Bone Graft Substitute Market, Global, 2019 - 2029 (US$)
  • Figure 5-68: Market Value by Region, Synthetic Bone Graft Substitute Market, Global, 2019 - 2029 (US$M)
  • Figure 5-69: Allograft Bone Graft Substitute Units Sold by Indication, Global, 2019 - 2029
  • Figure 5-70: Spine Allograft Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-71: Trauma Allograft Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-72: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-73: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication, Global, 2019 - 2029
  • Figure 5-74: Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-75: Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-76: Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-77: Synthetic Bone Graft Substitute Units Sold by Indication, Global, 2019 - 2029
  • Figure 5-78: Spine Synthetic Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-79: Trauma Synthetic Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-80: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold, Global, 2019 - 2029
  • Figure 5-81: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2022
  • Figure 6-1: Orthopedic Growth Factor Procedures by Region, Global, 2019 - 2029
  • Figure 6-2: Orthopedic Growth Factor Procedures by Country, North America, 2019 - 2029
  • Figure 6-3: Orthopedic Growth Factor Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 6-4: Orthopedic Growth Factor Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 6-5: Orthopedic Growth Factor Procedures by Country, Western Europe, 2019 - 2029
  • Figure 6-6: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 6-7: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 6-8: Orthopedic Growth Factor Procedures by Country, Middle East, 2019 - 2029
  • Figure 6-9: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 6-10: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 6-11: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 6-12: Orthopedic Growth Factor Procedures by Country, Africa, 2019 - 2029
  • Figure 6-13: Orthopedic Growth Factor Market, Global, 2019 - 2029
  • Figure 6-14: Units Sold by Region, Orthopedic Growth Factor Market, Global, 2019 - 2029
  • Figure 6-15: Average Selling Price by Region, Orthopedic Growth Factor Market, Global, 2019 - 2029 (US$)
  • Figure 6-16: Market Value by Region, Orthopedic Growth Factor Market, Global, 2019 - 2029 (US$M)
  • Figure 6-17: Leading Competitors, Orthopedic Growth Factor Market, Global, 2022
  • Figure 7-1: Orthopedic Cell Therapy Procedures by Segment, Global, 2019 - 2029
  • Figure 7-2: Orthopedic Cell Therapy Procedures by Region, Global, 2019 - 2029
  • Figure 7-3: Orthopedic Cell Therapy Procedures by Country, North America, 2019 - 2029
  • Figure 7-4: Orthopedic Cell Therapy Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 7-5: Orthopedic Cell Therapy Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 7-6: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2019 - 2029
  • Figure 7-7: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 7-8: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 7-9: Orthopedic Cell Therapy Procedures by Country, Middle East, 2019 - 2029
  • Figure 7-10: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 7-11: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 7-12: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 7-13: Orthopedic Cell Therapy Procedures by Country, Africa, 2019 - 2029
  • Figure 7-14: Orthopedic Platelet-Rich-Plasma Procedures by Region, Global, 2019 - 2029
  • Figure 7-15: Orthopedic Platelet-Rich-Plasma Procedures by Country, North America, 2019 - 2029
  • Figure 7-16: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 7-17: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 7-18: Orthopedic Platelet-Rich-Plasma Procedures by Country, Western Europe, 2019 - 2029
  • Figure 7-19: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 7-20: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 7-21: Orthopedic Platelet-Rich-Plasma Procedures by Country, Middle East, 2019 - 2029
  • Figure 7-22: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 7-23: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 7-24: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 7-25: Orthopedic Platelet-Rich-Plasma Procedures by Country, Africa, 2019 - 2029
  • Figure 7-26: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Region, Global, 2019 - 2029
  • Figure 7-27: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, North America, 2019 - 2029
  • Figure 7-28: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 7-29: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 7-30: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Western Europe, 2019 - 2029
  • Figure 7-31: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 7-32: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 7-33: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Middle East, 2019 - 2029
  • Figure 7-34: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 7-35: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 7-36: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 7-37: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Africa, 2019 - 2029
  • Figure 7-38: Orthopedic Cell Therapy Device Market by Segment, Global, 2019 - 2029 (US$M)
  • Figure 7-39: Orthopedic Cell Therapy Device Market by Region, Global, 2019 - 2029 (US$M)
  • Figure 7-40: Platelet-Rich Plasma Market, Global, 2019 - 2029
  • Figure 7-41: Units Sold by Region, Platelet-Rich Plasma Market, Global, 2019 - 2029
  • Figure 7-42: Average Selling Price by Region, Platelet-Rich Plasma Market, Global, 2019 - 2029 (US$)
  • Figure 7-43: Market Value by Region, Platelet-Rich Plasma Market, Global, 2019 - 2029 (US$M)
  • Figure 7-44: Bone Marrow Aspirate Concentrate Market, Global, 2019 - 2029
  • Figure 7-45: Units Sold by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 - 2029
  • Figure 7-46: Average Selling Price by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 - 2029 (US$)
  • Figure 7-47: Market Value by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 - 2029 (US$M)
  • Figure 7-48: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2022
  • Figure 8-1: Hyaluronic Acid Viscosupplementation Regions Covered, Global (1 of 2)
  • Figure 8-2: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2019 - 2029
  • Figure 8-3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, North America, 2019 - 2029
  • Figure 8-4: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2019 - 2029 (1 of 2)
  • Figure 8-5: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2019 - 2029 (2 of 2)
  • Figure 8-6: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Western Europe, 2019 - 2029
  • Figure 8-7: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2)
  • Figure 8-8: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2)
  • Figure 8-9: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Middle East, 2019 - 2029
  • Figure 8-10: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3)
  • Figure 8-11: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3)
  • Figure 8-12: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3)
  • Figure 8-13: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Africa, 2019 - 2029
  • Figure 8-14: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2019 - 2029 (US$M)
  • Figure 8-15: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2019 - 2029 (US$M)
  • Figure 8-16: Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-17: Units Sold by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-18: Average Selling Price by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$)
  • Figure 8-19: Market Value by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$M)
  • Figure 8-20: Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-21: Units Sold by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-22: Average Selling Price by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$)
  • Figure 8-23: Market Value by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$M)
  • Figure 8-24: Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-25: Units Sold by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-26: Average Selling Price by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$)
  • Figure 8-27: Market Value by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$M)
  • Figure 8-28: Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-29: Units Sold by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-30: Average Selling Price by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$)
  • Figure 8-31: Market Value by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$M)
  • Figure 8-32: Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-33: Units Sold by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029
  • Figure 8-34: Average Selling Price by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$)
  • Figure 8-35: Market Value by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 - 2029 (US$M)
  • Figure 8-36: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2022
  • Figure 9-1: Orthopedic Cartilage Repair Regions Covered, Global (1 of 2)
  • Figure 9-2: Orthopedic Cartilage Repair Regions Covered, Global (2 of 2)
  • Figure 9-3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2019 - 2029
  • Figure 9-4: Orthopedic Cartilage Repair Procedures by Region, Global, 2019 - 2029
  • Figure 9-5: Osteochondral Allograft Procedures by Region, Global, 2019 - 2029
  • Figure 9-6: Meniscal Allograft Procedures by Region, Global, 2019 - 2029
  • Figure 9-7: Autologous Chondrocyte Implantation Procedures by Region, Global, 2019 - 2029
  • Figure 9-8: Orthopedic Cartilage Repair Device Market by Segment, Global, 2019 - 2029 (US$M)
  • Figure 9-9: Orthopedic Cartilage Repair Device Market by Region, Global, 2019 - 2029 (US$M)
  • Figure 9-10: Orthopedic Cartilage Repair Market, Global, 2019 - 2029
  • Figure 9-11: Units Sold by Region, Orthopedic Cartilage Repair Market, Global, 2019 - 2029
  • Figure 9-12: Average Selling Price by Region, Orthopedic Cartilage Repair Market, Global, 2019 - 2029 (US$)
  • Figure 9-13: Market Value by Region, Orthopedic Cartilage Repair Market, Global, 2019 - 2029 (US$M)
  • Figure 9-14: Osteochondral Allograft Market, Global, 2019 - 2029
  • Figure 9-15: Units Sold by Region, Osteochondral Allograft Market, Global, 2019 - 2029
  • Figure 9-16: Average Selling Price by Region, Osteochondral Allograft Market, Global, 2019 - 2029 (US$)
  • Figure 9-17: Market Value by Region, Osteochondral Allograft Market, Global, 2019 - 2029 (US$M)
  • Figure 9-18: Meniscal Allograft Market, Global, 2019 - 2029
  • Figure 9-19: Units Sold by Region, Meniscal Allograft Market, Global, 2019 - 2029
  • Figure 9-20: Average Selling Price by Region, Meniscal Allograft Market, Global, 2019 - 2029 (US$)
  • Figure 9-21: Market Value by Region, Meniscal Allograft Market, Global, 2019 - 2029 (US$M)
  • Figure 9-22: Autologous Chondrocyte Implantation Market, Global, 2019 - 2029
  • Figure 9-23: Units Sold by Region, Autologous Chondrocyte Implantation Market, Global, 2019 - 2029
  • Figure 9-24: Average Selling Price by Region, Autologous Chondrocyte Implantation Market, Global, 2019 - 2029 (US$)
  • Figure 9-25: Market Value by Region, Autologous Chondrocyte Implantation Market, Global, 2019 - 2029 (US$M)
目次
Product Code: iDATA_GLOB23_MS

In 2022, the global orthopedic biomaterials device market was valued at $5.6 billion. This is anticipated to increase over the forecast period at a CAGR of 3.4% to reach $7.1 billion.

The full report suite on the global market for orthopedic biomaterials includes bone graft substitutes, growth factors, cell therapy, hyaluronic acid viscosupplementation and cartilage repair (appendix only).

MARKET REPORT DATA TYPES INCLUDED:

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2028, and Historical Data to 2018
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Procedure Volumes
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • COVID-19 Impact Analysis

GLOBAL ORTHOPEDIC BIOMATERIALS MARKET TRENDS

By the year 2030, elder persons are anticipated to outnumber children under the age of 10 (1.41 billion versus 1.35 billion), and, by 2050, projections indicate that there will be a greater number of persons aged 60 or over than adolescents aged 10-24 (2.1 billion versus 2.0 billion). The aging of the population will significantly impact the orthopedic biomaterials device market, increasing the prevalence of bone diseases and the need for treating them. However, orthopedic biomaterials device markets were negatively impacted by COVID-19 in the short term due to mass cancellations and postponements of procedures across all countries.

GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SHARE INSIGHTS

Overall, within the Global orthopedic biomaterials market there are three leading competitors: Medtronic, DePuy Synthes, and Stryker. Medtronic has maintained a strong presence in the total orthopedic Biomaterials device market through a variety of characteristics including brand recognition, strong customer support and a large sales force. The company held the largest share of the orthopedic bone graft substitute segment and dominated in the orthopedic growth factor market because of the success of its INFUSE™ product.

MARKET SEGMENTATION SUMMARY

You can view all these included reports and segmentation here:

  • Orthopedic Bone Graft Substitutes Market - MedCore - Includes:
    • Allograft BGS, demineralized bone matrix allograft BGS and synthetic BGS.
  • Orthopedic Growth Factor Market - MedCore
  • Orthopedic Cell Therapy Market - MedCore - Includes:
    • Platelet-rich plasma and bone marrow therapy segments.
  • Hyaluronic Acid Viscosupplementation Market - MedCore - Includes:
    • Single-injection, Two-injection, Three-Injection, and Five-Injection products.
  • In Appendix* Orthopedic Cartilage Repair Market - MedCore - Includes:
    • Osteochondral allografts, meniscal allografts, and autologous chondrocytes.

RESEARCH SCOPE SUMMARY

  • Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
  • Base Year: 2022
  • Forecast: 2023-2029
  • Historical Data: 2019-2022
  • Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
  • Qualitative Coverage: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
  • Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

TABLE OF CONTENT

  • TABLE of CONTENTS
  • List of Figures
  • List of Charts
  • executive summary
  • Global Orthopedic Biomaterials Device Market Overview
  • Competitive Analysis
  • Market Trends
  • Market Developments
  • Procedures Included
  • Markets Included
  • Regions Included
  • Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE global Orthopedic Biomaterials DEVICE Market

  • 2.1. Introduction
  • 2.2. Regional Profiles
  • 2.3. Analysis By Market Segment
    • 2.3.1. Worst Case Scenario
    • 2.3.2. Base Case Scenario
    • 2.3.3. Best Case Scenario

Product Assessment

  • 3.1. Introduction
  • 3.2. Product Portfolios
    • 3.2.1. Bone Graft Substitute
    • 3.2.2. Growth Factors
      • 3.2.2.1.1. NELL-1 Bone Biologics
      • 3.2.2.1.2. INFUSE® by Medtronic
      • 3.2.2.1.3. OsteoAMP® by Bioventus Surgical
      • 3.2.2.1.4. OP-1™ by Stryker/Olympus Biotech (Delisted)
      • 3.2.2.1.5. The Osteogrow Study
      • 3.2.2.1.6. AUGMENT® Bone Graft
      • 3.2.2.1.7. Amplex® Osteobiologic Bone Graft Substitute
      • 3.2.2.1.8. i-Factor™ Peptide Bone Matrix
    • 3.2.3. Cell Therapy
      • 3.2.3.1. Platelet-Rich Plasma
      • 3.2.3.2. Bone Marrow Aspirate Concentrate
    • 3.2.4. Hyaluronic Acid Viscosupplementation (HAV)
    • 3.2.5. Cartilage Repair
  • 3.3. Regulatory Issues and Recalls
    • 3.3.1. Bioventus
      • 3.3.1.1. Bone Graft Substitute
    • 3.3.2. Cerapedics
      • 3.3.2.1. Growth Factor
    • 3.3.3. Exactech
      • 3.3.3.1. Bone Graft Substitute
    • 3.3.4. Medtronic
      • 3.3.4.1. Bone Graft Substitute
    • 3.3.5. Sanofi
      • 3.3.5.1. Hyaluronic Acid Viscosupplementation
    • 3.3.6. Wright Medical (Stryker)
      • 3.3.6.1. Bone Graft Substitute
    • 3.3.7. Xtant
      • 3.3.7.1. Bone Graft Substitute
    • 3.3.8. Zimmer Biomet
      • 3.3.8.1. Growth Factor
  • 3.4. Clinical Trials
    • 3.4.1. Aesculap
      • 3.4.1.1. Cartilage Repair
    • 3.4.2. Arthrex
      • 3.4.2.1. Bone Graft Substitute
    • 3.4.3. Cerapedics
      • 3.4.3.1. Bone Graft Substitute
    • 3.4.4. Medtronic
      • 3.4.4.1. Growth Factor
    • 3.4.5. Surgalign Holdings
      • 3.4.5.1. Bone Graft Substitute
    • 3.4.6. Stryker
      • 3.4.6.1. Bone Graft Substitute
    • 3.4.7. Tetec
      • 3.4.7.1. Cartilage Repair
    • 3.4.8. Vericel
      • 3.4.8.1. Cartilage Repair
    • 3.4.9. Others
      • 3.4.9.1. Bone Graft Substitute
      • 3.4.9.2. Growth Factor
      • 3.4.9.3. Cell Therapy
      • 3.4.9.4. Hyaluronic Acid Viscosupplementation
      • 3.4.9.5. Cartilage Repair

Global Orthopedic Biomaterials Device Market Overview

  • 4.1. Introduction
  • 4.2. Market Overview & Trend Analysis
    • 4.2.1. By Segment
    • 4.2.2. By Region
  • 4.3. Drivers and Limiters
    • 4.3.1. Market Drivers
    • 4.3.2. Market Limiters
  • 4.4. Competitive Market Share Analysis
  • 4.5. Mergers and Acquisitions
  • 4.6. Company Profiles
    • 4.6.1. Arthrex
    • 4.6.2. Bioventus
    • 4.6.3. DePuy Synthes
    • 4.6.4. Ferring Pharmaceuticals
    • 4.6.5. Fidia Farmaceutici
    • 4.6.6. Harvest Technologies (Terumo BCT)
    • 4.6.7. Medtronic
    • 4.6.8. Musculoskeletal Transplant Foundation (MTF)
    • 4.6.9. Surgalign Holdings (former RTI Surgical)
    • 4.6.10. Sanofi
    • 4.6.11. SeaSpine
    • 4.6.12. Stryker
    • 4.6.13. Vericel
    • 4.6.14. Zimmer Biomet
  • 4.7. SWOT Analysis
    • 4.7.1. Arthrex
    • 4.7.2. Bioventus
    • 4.7.3. DePuy Synthes
    • 4.7.4. Ferring Pharmaceuticals
    • 4.7.5. Fidia Farmaceutici
    • 4.7.6. Harvest Technologies (Terumo BCT)
    • 4.7.7. Medtronic
    • 4.7.8. Musculoskeletal Transplant Foundation (MTF)
    • 4.7.9. Surgalign Holdings (former RTI Surgical)
    • 4.7.10. Sanofi
    • 4.7.11. SeaSpine
    • 4.7.12. Stryker
    • 4.7.13. Vericel
    • 4.7.14. Zimmer Biomet

Orthopedic Bone Graft Substitute Market

  • 5.1. Executive Summary
    • 5.1.1. Global Orthopedic Bone Graft Substitute Market Overview
    • 5.1.2. Competitive Analysis
    • 5.1.3. Regions Included
  • 5.2. Introduction
  • 5.3. Procedure Numbers
    • 5.3.1. Total Orthopedic Bone Grafting Procedures
    • 5.3.2. Allograft Procedures
    • 5.3.3. Demineralized Bone Matrix Procedures
    • 5.3.4. Synthetic Procedures
  • 5.4. Market Overview
    • 5.4.1. By Segment
    • 5.4.2. By Region
  • 5.5. Market Analysis and Forecast
    • 5.5.1. Total Orthopedic Bone Graft Substitute Market
    • 5.5.2. Allograft Bone Graft Substitute Market
    • 5.5.3. Demineralized Bone Matrix Allograft Bone Graft Substitute Market
    • 5.5.4. Synthetic Bone Graft Substitute Market
  • 5.6. Unit Analysis
    • 5.6.1. Allograft Bone Graft Substitute Unit Analysis
      • 5.6.1.1. Allograft Bone Graft Substitute Units Sold by Indication
    • 5.6.2. Demineralized Bone Matrix Allograft Bone Graft Substitute Unit Analysis
      • 5.6.2.1. Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication
    • 5.6.3. Synthetic Bone Graft Substitute Unit Analysis
      • 5.6.3.1. Synthetic Bone Graft Substitute Units Sold by Indication
  • 5.7. Drivers and Limiters
    • 5.7.1. Market Drivers
    • 5.7.2. Market Limiters
  • 5.8. Competitive Market Share Analysis

Orthopedic Growth Factor Market

  • 6.1. Executive Summary
    • 6.1.1. Global Orthopedic Growth Factor Market Overview
    • 6.1.2. Competitive Analysis
    • 6.1.3. Regions Included
  • 6.2. Introduction
  • 6.3. Procedure Numbers
  • 6.4. Market Analysis and Forecast
  • 6.5. Drivers and Limiters
    • 6.5.1. Market Drivers
    • 6.5.2. Market Limiters
  • 6.6. Competitive Market Share Analysis

Orthopedic Cell Therapy Market

  • 7.1. Executive Summary
    • 7.1.1. Global Orthopedic Cell Therapy Market Overview
    • 7.1.2. Competitive Analysis
    • 7.1.3. Regions Included
  • 7.2. Introduction
    • 7.2.1. Platelet-Rich Plasma
    • 7.2.2. Concentrated Bone Marrow Aspirate
  • 7.3. Procedure Numbers
    • 7.3.1. Total Orthopedic Cell Therapy Procedures
    • 7.3.2. Platelet-Rich Plasma Procedures
    • 7.3.3. Bone Marrow Aspirate Concentrate Procedures
  • 7.4. Market Overview
    • 7.4.1. By Segment
    • 7.4.2. By Region
  • 7.5. Market Analysis and Forecast
    • 7.5.1. Platelet-Rich Plasma Market
    • 7.5.2. Bone Marrow Aspirate Concentrate Market
  • 7.6. Drivers and Limiters
    • 7.6.1. Market Drivers
    • 7.6.2. Market Limiters
  • 7.7. Competitive Market Share Analysis

Hyaluronic Acid Viscosupplementation Market

  • 8.1. Executive Summary
    • 8.1.1. Global Hyaluronic Acid Viscosupplementation Market Overview
    • 8.1.2. Competitive Analysis
    • 8.1.3. Regions Included
  • 8.2. Introduction
    • 8.2.1. Benefits of Viscosupplementation
    • 8.2.2. Synovial Fluid
    • 8.2.3. Product Types
      • 8.2.3.1. Single-Injection Products
      • 8.2.3.2. Two-Injection Cycle Products
      • 8.2.3.3. Three-Injection Cycle Products
      • 8.2.3.4. Three-/Five-Injection Cycle Products
  • 8.3. Procedure Numbers
  • 8.4. Market Overview
    • 8.4.1. By Segment
    • 8.4.2. By Region
  • 8.5. Market Analysis and Forecast
    • 8.5.1. Total Hyaluronic Acid Viscosupplementation Market
    • 8.5.2. Single-Injection Hyaluronic Acid Viscosupplementation Market
    • 8.5.3. Two-Injection Hyaluronic Acid Viscosupplementation Market
    • 8.5.4. Three-Injection Hyaluronic Acid Viscosupplementation Market
    • 8.5.5. Five-Injection Hyaluronic Acid Viscosupplementation Market
  • 8.6. Drivers and Limiters
    • 8.6.1. Market Drivers
    • 8.6.2. Market Limiters
  • 8.7. Competitive Market Share Analysis

Appendix: Orthopedic Cartilage Repair Market

  • 9.1. Executive Summary
    • 9.1.1. Global Orthopedic Cartilage Repair Market Overview
    • 9.1.2. Regions Included
  • 9.2. Introduction
    • 9.2.1. Anatomy
    • 9.2.2. Methods for Cartilage Repair
      • 9.2.2.1. Microfracture
      • 9.2.2.2. Microfracture Adjunct
      • 9.2.2.3. Osteoarticular Autograft Transfer System
      • 9.2.2.4. Particulated Juvenile Allograft
      • 9.2.2.5. Osteochondral Allograft Transfer
      • 9.2.2.6. Autologous Chondrocyte Implantation
      • 9.2.2.7. Meniscal Allograft Transplantation
  • 9.3. Procedure Numbers
    • 9.3.1. Total Orthopedic Cartilage Repair Procedures
    • 9.3.2. Osteochondral Allograft Procedures
    • 9.3.3. Meniscal Allograft Procedures
    • 9.3.4. Autologous Chondrocyte Implantation Procedures
  • 9.4. Market Overview
    • 9.4.1. By Segment
    • 9.4.2. By Region
  • 9.5. Market Analysis and Forecast
    • 9.5.1. Total Orthopedic Cartilage Repair Market
    • 9.5.2. Osteochondral Allograft Market
    • 9.5.3. Meniscal Allograft Market
    • 9.5.4. Autologous Chondrocyte Implantation Market
  • 9.6. Drivers and Limiters
    • 9.6.1. Market Drivers
    • 9.6.2. Market Limiters
  • 9.7. Competitive Market Share Analysis

Abbreviations